The DEA is placing four synthetic cannabinoid compounds into Schedule I, designating them as controlled substances with no accepted medical use. This reflects updated drug classification policy.
Plain language summary generated by AI · Civitics
Revision of Applications for Manufacturing and Procurement Quotas NPRM
Schedules of Controlled Substances: Removal of Exemption Status for Inactive Butalbital Products
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I